Gut microbiome, probiotics, gut-brain axis, and digestive health
324 articles
45 studies reveal how specific probiotic strains modulate the gut-brain axis to combat depression through SCFAs, GABA, and serotonin.
A gut bacterium celebrated for metabolic benefits may have a complex, sometimes harmful role in stroke, Parkinson's, Alzheimer's, and MS.
A common oat fiber supercharges anti-PD-1 checkpoint therapy by expanding a key gut microbe that produces immune-activating metabolites.
Western diets reduce microbial diversity in Lynch syndrome, while plant proteins boost beneficial bacteria linked to colorectal cancer protection.
A new review maps the structural and functional changes that help the bowel compensate after resection, and highlights where knowledge gaps remain.
Harvard researchers find lasting microbiome and metabolome shifts after adenoma resection that mirror colorectal cancer signatures.
A landmark review reveals how diet, gut bacteria, and their metabolites determine the success of immune checkpoint blockade cancer therapy.
A corrigendum updates the EEDBI Consortium's mucosal investigation of environmental enteric dysfunction published in 2024.
A case report from China documents atypical diarrhea in an immunocompetent infant, raising questions about rare GI diagnoses in young children.
Aging disrupts gut microbiota and mTOR signaling, crippling vaccine responses — but targeted interventions may reverse this.
Gut microbes deploy reversible DNA methylation changes to adapt to antibiotics and fecal transplants — even beneficial Akkermansia uses this strategy.
A fetal enzyme floods newborns with hyocholic acids that train immune tolerance and shape a healthy gut microbiome—then disappear by adulthood.
